Accelerate Diagnostics, Inc. (AXDX)

Accelerate Diagnostics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	12.17	12.06	12.75	11.78	11.17	9.3
Revenue Growth (YoY)	-3.47%	-5.43%	8.23%	5.53%	20.09%	63.97%
Cost of Revenue	9.91	9.51	9.45	12.16	6.71	4.9
Gross Profit	2.26	2.55	3.3	-0.38	4.46	4.4
Selling, General & Admin	26.82	31.23	39.19	49.24	46.9	51.89
Research & Development	23.56	25.35	26.92	21.94	21.26	25.35
Operating Expenses	50.38	56.58	66.11	71.18	68.16	77.23
Operating Income	-48.12	-54.03	-62.81	-71.56	-63.7	-72.83
Interest Expense / Income	8.76	7.74	3.77	15.55	15.55	14.26
Other Expense / Income	1.32	-1	-4.01	-9.45	-1.05	-2.67
Pretax Income	-58.2	-60.77	-62.57	-77.66	-78.2	-84.42
Income Tax	0.85	0.85	-0.08	0.05	0.01	-0.11
Net Income	-59.05	-61.62	-62.49	-77.7	-78.21	-84.31
Shares Outstanding (Basic)	19	12	8	6	6	5
Shares Outstanding (Diluted)	19	12	8	6	6	5
Shares Change	95.48%	51.86%	33.10%	10.21%	2.76%	0.02%
EPS (Basic)	-4.46	-4.94	-7.61	-12.59	-14.00	-15.50
EPS (Diluted)	-4.46	-4.94	-7.61	-12.59	-14.00	-15.50
Free Cash Flow	-36.82	-41.23	-49.28	-47.93	-51.76	-65.12
Free Cash Flow Per Share	-1.92	-3.31	-6.00	-7.76	-9.24	-11.95
Gross Margin	18.59%	21.15%	25.90%	-3.23%	39.94%	47.33%
Operating Margin	-395.47%	-448.03%	-492.51%	-607.37%	-570.53%	-783.38%
Profit Margin	-485.31%	-510.97%	-490.06%	-659.50%	-700.47%	-906.80%
Free Cash Flow Margin	-302.57%	-341.91%	-386.46%	-406.77%	-463.56%	-700.48%
EBITDA	-46.13	-49.77	-55.8	-59.59	-59.66	-67.56
EBITDA Margin	-379.11%	-412.73%	-437.57%	-505.81%	-534.31%	-726.66%
Depreciation & Amortization	3.31	3.25	3	2.52	3	2.6
EBIT	-49.44	-53.03	-58.8	-62.11	-62.65	-70.16
EBIT Margin	-406.31%	-439.71%	-461.10%	-527.18%	-561.16%	-754.65%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).